Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment.
about
Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates.Osteoporosis treatment: why ibandronic acid?Health-related quality of life among patients with postmenopausal osteoporosis treated with weekly and monthly bisphosphonates.Influence of gastrointestinal events on treatment of osteoporosis in Asia-Pacific women: Perspectives from physicians in the MUSIC OS-AP study.
P2860
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gastrointestinal tolerability ...... ekly bisphosphonate treatment.
@en
Gastrointestinal tolerability ...... ekly bisphosphonate treatment.
@nl
type
label
Gastrointestinal tolerability ...... ekly bisphosphonate treatment.
@en
Gastrointestinal tolerability ...... ekly bisphosphonate treatment.
@nl
prefLabel
Gastrointestinal tolerability ...... ekly bisphosphonate treatment.
@en
Gastrointestinal tolerability ...... ekly bisphosphonate treatment.
@nl
P2860
P356
P1476
Gastrointestinal tolerability ...... eekly bisphosphonate treatment
@en
P2093
Ann Babbitt
Joseph D Kohles
P2860
P304
P356
10.2147/CIA.S5637
P407
P577
2009-10-12T00:00:00Z